ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SLDB Solid Biosciences Inc

10.23
0.00 (0.00%)
Pre Market
Last Updated: 12:00:03
Delayed by 15 minutes
Share Name Share Symbol Market Type
Solid Biosciences Inc NASDAQ:SLDB NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.23 8.02 13.00 0 12:00:03

SOLID BIOSCIENCES 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors with Losses in Excess ...

28/05/2018 3:50am

Business Wire


Solid Biosciences (NASDAQ:SLDB)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Solid Biosciences Charts.

ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until May 28, 2018 to file lead plaintiff applications in a securities class action lawsuit against Solid Biosciences Inc. (NasdaqGS: SLDB). Investor losses must relate to purchases of the Company’s shares between January 25, 2018, and March 14, 2018 or in its January 25, 2018 initial public offering. This action is pending in the United States District Court for the District of Massachusetts.

Get Help

Solid Biosciences investors should visit us at https://www.claimsfiler.com/cases/view-solid-biosciences-inc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.

About the Lawsuit

On March 14, 2018, the Company disclosed a clinical hold placed on the trial of its lead drug candidate, SGT-001, by the U.S. Food and Drug Administration relating to the occurrence of adverse events. On this news, the price of Solid Biosciences’ shares plummeted over 60% to $9.32/share on March 15, 2018.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler’s team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.

To learn more about ClaimsFiler, visit www.claimsfiler.com.

ClaimsFilerJerry Gallo, 844-367-9658https://www.claimsfiler.com

1 Year Solid Biosciences Chart

1 Year Solid Biosciences Chart

1 Month Solid Biosciences Chart

1 Month Solid Biosciences Chart

Your Recent History

Delayed Upgrade Clock